Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 4 , Pages 687-710, December 2007

PPAR agonists: multimodal drugs for the treatment of type-2 diabetes

  • Bart Staels, PhD (Professor and Head of Laboratory)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +33 3 20 87 73 88; Fax: +33 3 20 87 71 98.

Institut Pasteur de Lille, 1 rue du Prof Calmette, Lille, F-59019, France

Inserm, U545, Lille, F-59019, France

Université de Lille 2, Faculté des Sciences Pharmaceutiques et Biologiques et Faculté de Médecine, Lille, F-59006, France

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(07)00088-7

doi:10.1016/j.beem.2007.09.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 4 , Pages 687-710, December 2007

Article Tools